Die verlängerte Sekundärprophylaxe nach venöser Thrombose

Thromboembolische Erkrankungen - Erhaltungstherapie - Rezidivhäufigkeit - verlängerte Sekundärprophylaxe - Triggerfaktor - provoziert - unprovoziert - Ampelprinzip

References

Literatur
1 Hach-Wunderle V, Gerlach H, Konstantinides S. et al. Interdisziplinäre S2k: Leitlinie: Diagnostik und Therapie der Bein- und Beckenvenenthrombose und der Lungenembolie; Registernummer 065 – 002. VASA 2016; 45: 1-48.
2 Kearon C, Akl EA, Ornelas J. et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149: 315-352.
3 Limone BL, Hernandez AV, Michalak D, Bookhart BK, Coleman Cl. Timing of recurrent venous thromboembolism early after the index event: a meta-analysis of randomized controlled trials. Thromb Res 2013; 132: 420-426.
4 Agnelli G, Buller HR, Cohen A. et al. Apixaban for Extended Treatment of Venous Thromboembolism. N Engl J Med 2012; 368: 699-708.
5 Brighton TA, Eikelboom JW, Mann K. et al. Lowdose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 2012; 367: 1979-1987.
6 Becattini C, Agnelli G, Schenone A. et al. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 2012; 366: 1959-1967.
7 Brighton TA, Eikelboom JW, Mann K. et al. Lowdose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 2012; 367: 1979-1987.
8 Kearon C, Ageno W, Cannegieter SC. et al. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost 2016; 14: 1480-1483.
9 Bauersachs R. Akuttherapie und prolongierte Sekundärprävention Venöser Thromboembolien. In: Lindhoff-Last E, Debus ES, Kellersmann R, Tepe G. eds, Angio Update: Handbuch Gefässmedizin 2017. Wiesbaden: med publico GmbH; 2017: 1-37.
10 Weitz JI, Lensing AW, Prins MH. et al. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism. N Engl J Med 2017; 376: 1211-1222.
11 Prins MH, Lensing AWA, Prandoni P. et al. OC 39.1 Long-term Risk of Recurrent Venous Thromboembolism with and without Effective Antithrombotic. Therapy Res Pract Thromb Haemost 2017; 01: 187.
12 Bauersachs R, Agnelli G, Gitt AK. et al. The role of heparin lead-in in the real-world management of acute venous thromboembolism: The PREFER in VTE registry. Thromb Res 2017; 157: 181-188.
13 Bauersachs R. Verlängerte Sekundärprophylaxe nach venöser Thromboembolie. Dtsch Med Wochenschr 2018; 143: 1-6.
14 Cohen AT, Gitt AK, Bauersachs R. et al. The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry. Thromb Haemost 2017; 117: 1326-1337.